Bilateral Putaminal Necrosis Associated With the Mitochondrial DNA A8344G Myoclonus Epilepsy With Ragged Red Fibers (MERRF) Mutation: An Infantile Case

Abstract

Myoclonus epilepsy with ragged red fibers (MERRF) is one of the major mitochondrial encephalomyopathies. Its main clinical features are myoclonus epilepsy, ataxia, and myopathy with ragged red fibers. Whereas there is a close correlation between MERRF syndrome and the A8344G mutation of mitochondrial DNA, the reverse is not true. In fact, this mutation is also responsible for various other syndromes, such as Leigh syndrome, spinocerebellar degeneration, atypical Charcot-Marie-Tooth disease, and multiple truncal lipomas. We describe a child with the A8344G mutation of mitochondrial DNA and an unusual clinical, neuroradiologic, and biochemical phenotype, characterized by early-onset, nonprogressive cerebellar ataxia, and subclinical myoclonias in association with bilateral putaminal necrosis on magnetic resonance imaging and a reduction in complex V activity. Our case confirms the existence of a relationship between alteration in adenosine triphosphatase activity and basal ganglia involvement. We recommend that the possibility of a mitochondrial pathology should always be taken into consideration in the presence of bilateral symmetric lesions of the basal ganglia, even when the typical clinical picture is lacking. (J Child Neurol 2006;21:79—82).

Get full access to this article

View all access options for this article.

References

Fukuhara N. , Tokiguchi S. , Shirakawa K. , Tsubaki T. : Myoclonus epilepsy associated with ragged-red fibers (mitochondrial abnormalities): Disease entity or a syndrome? Light-and electron-microscopic studies of two cases and review of literature. J Neurol Sci 1980;47:117—133.

Silvestri G. , Ciafaloni E. , Santorelli FM , et al: Clinical features associated with the A→G transition at nucleotide 8344 of mitochondrial DNA (“MERRF mutation”). Neurology 1993;43:1200—1206.

Sweeney MG , Hammans SR , Duchen LW , et al: Mitochondrial DNA mutation underlying Leigh's syndrome: Clinical, pathological, biochemical, and genetic studies of a patient presenting with progressive myoclonic epilepsy. J Neurol Sci 1994; 121:57-65.

Howell N. , Kubacka I. , Smith R. , et al: Association of the mitochondrial 8344 MERRF mutation with maternally inherited spinocerebellar degeneration and Leigh disease. Neurology 1996;46:219—222.

Santorelli FM , Casali C. : Genetic heterogeneity of myoclonus epilepsy with ragged-red fibers syndrome. Muscle Nerve 1998;21:681—682.

Davis PC , Hoffman JC Jr , Braun IF , et al: MR of Leigh's disease (sub-acute necrotizing encephalomyelopathy) AJNR Am J Neuroradiol 1987;8:71—75.

Ragan CI , Wilson MT , Darley-Usmar VM , Lowe PN : Sub-fractionation of mitochondria and isolation of the proteins of oxidative phosphorylation, in: Darley-Usmar VM , Rickwood A , Wilson MT (eds): Mitochondria: A Practical Approach. Oxford, UK, IRL Press,1987, 79-112.

Santorelli FM , Mak SC , Vazquez-Memije E. , et al: Clinical heterogeneity associated with the mitochondrial DNA T8993C point mutation. Pediatr Res 1996;39:914—917.

Zeviani M. , Amati P. , Bresolin N. , et al: Rapid detection of the A→G(8344) mutation of mtDNA in Italian families with myoclonus epilepsy and ragged-red fibers (MERRF). Am J Hum Genet 1991;48:203—211.

10.

Krahenbuhl S. , Brandner S. , Kleinle S. , et al: Mitochondrial diseases represent a risk factor for valproate-induced fulminant liver failure. Liver 2000;20:346—348.

11.

Nissenkorn A. , Zeharia A. , Lev D. , et al: Neurologic presentations of mitochondrial disorders. J Child Neurol 2000;15:44—48.

12.

Martinez Bermejo A , Arcas J. , Roche MC , et al: Bilateral hypodensity of the basal ganglia. Clinico-evolutionary correlation in children. Rev Neurol 2001;33:101—111.

13.

Roberge RJ , Srinivasa NS , Frank LR , et al: Putaminal infarct in methanol intoxication: Case report and role of brain imaging studies. Vet Hum Toxicol 1998;40:95—98.

14.

Rubinstein D. , Escott E. , Kelly JP : Methanol intoxication with putaminal and white matter necrosis: MR and CT findings. AJNR Am J Neuroradiol 1995;16:1492—1494.

15.

Kawano H. , Takeuchi Y. , Misawa A. , et al: Putaminal necrosis presenting with hemidystonia. Pediatr Neurol 2000;22:222—224.

16.

Roig M. , Calopa M. , Rovira A. , et al: Bilateral striatal lesions in childhood. Pediatr Neurol 1993;9:349—358.

17.

Straussberg R. , Shorer Z. , Weitz R. , et al: Familial infantile bilateral striatal necrosis: Clinical features and response to biotin treatment. Neurology 2002;59:983—989.

18.

Thyagarajan D. , Shanske S. , Vazquez-Memije M. , et al: A novel mitochondrial ATPase 6 point mutation in familial bilateral striatal necrosis. Ann Neurol 1995;38:468—472.

19.

De Meirleir L. , Seneca S. , Lissens W. , et al: Bilateral striatal necrosis with a novel point mutation in the mitochondrial ATPase 6 gene. Pediatr Neurol 1995;13:242—246.

20.

Campos Y. , Martin MA , Rubio JC , et al: Bilateral striatal necrosis and MELAS associated with a new T3308C mutation in the mitochondrial ND1 gene. Biochem Biophys Res Commun 1997;238:323—325.

21.

Solano A. , Roig M. , Vives-Bauza C. , et al: Bilateral striatal necrosis associated with a novel mutation in the mitochondrial ND6 gene. Ann Neurol 2003;54:527—530.

22.

Basel-Vanagaite L. , Straussberg R. , Ovadia H. , et al: Infantile bilateral striatal necrosis maps to chromosome 19q. Neurology 2004;62:87—90.

23.

Schon EA , Santra S. , Pallotti F. , Girvin ME : Pathogenesis of primary defects in mitochondrial ATP synthesis. Semin Cell Dev Biol 2001; 12:441—448.

24.

DiMauro S. , Hirano M. , Kaufmann P. , et al: Clinical features and genetics of myoclonic epilepsy with ragged red fibers. Adv Neurol 2002;89:217—229.